Related Experiment Videos

Inhibition of NAD(H)/NADP(H)--requiring enzymes by aurintricarboxylic acid

D C Thompson1, M Reed

  • 1Department of Medical Pharmacology & Toxicology, College of Medicine, Texas A & M University Health Science Center, College Station 77843-1114, USA.

Toxicology Letters
|November 15, 1995
PubMed

Insights

Aurintricarboxylic acid (ATA) inhibits many NAD(H)/NADP(H)-requiring enzymes in vitro. However, ATA’s inhibitory effects are significantly reduced in cellular environments, challenging its use in toxicology studies.

Area of Science:

  • Biochemistry
  • Toxicology
  • Enzymology

Background:

  • Aurintricarboxylic acid (ATA) is commonly used to investigate the role of intracellular calcium in toxicology.
  • ATA is known to inhibit Ca(2+)-dependent endonuclease activity.

Purpose of the Study:

  • To investigate the inhibitory effects of ATA on various NAD(H)/NADP(H)-requiring enzymes.
  • To compare ATA's inhibitory potency in purified enzyme systems versus cellular homogenates.

Main Methods:

  • Enzyme inhibition assays were performed using purified NAD(H)/NADP(H)-requiring enzymes and rat liver Ca(2+)-dependent endonuclease.
  • Enzyme activity was also assessed in cellular homogenates.
  • The impact of exogenous protein on ATA's inhibitory activity was evaluated.

Main Results:

  • ATA potently inhibited most purified NAD(H)/NADP(H)-requiring enzymes (IC50s 0.5–82 μM), except for alcohol dehydrogenase.
  • In cellular homogenates, ATA was 10 to 100-fold less potent in inhibiting these enzymes.
  • The presence of exogenous protein diminished ATA's inhibitory effects on purified enzymes.

Conclusions:

  • ATA inhibits a broad spectrum of NAD(H)/NADP(H)-requiring enzymes in vitro.
  • ATA's inhibitory efficacy is substantially reduced in conditions mimicking a cellular environment, suggesting limitations for its use in mechanistic toxicology.

Related Concept Videos